v3.22.4
Consolidated Statements of Equity - USD ($)
shares in Millions, $ in Millions
Total
Common stock
Treasury stock
Additional paid-in capital
Retained earnings
Accumulated other comprehensive loss
Noncontrolling interest
Beginning balance at Dec. 31, 2019 $ (8,172) $ 18 $ (24,504) $ 15,193 $ 4,717 $ (3,596) $ 0
Beginning balance (in shares) at Dec. 31, 2019   1,479          
Increase (Decrease) in Stockholders' Equity              
Net earnings attributable to AbbVie Inc. 4,616 $ 0 0 0 4,616 0 0
Other comprehensive income, net of tax 479 0 0 0 0 479 0
Dividends declared (8,278) 0 0 0 (8,278) 0 0
Common shares and equity awards issued for acquisition of Allergan plc 24,409 $ 0 23,166 1,243 0 0 0
Common shares and equity awards issued for acquisition of Allergan plc (in shares)   286          
Purchases of treasury stock (978) $ 0 (978) 0 0 0 0
Purchases of treasury stock (in shares)   (10)          
Stock-based compensation plans and other 1,000 $ 0 52 948 0 0 0
Stock-based compensation plans and other (in shares)   10          
Change in noncontrolling interest 21 $ 0 0 0 0 0 21
Ending balance at Dec. 31, 2020 13,097 $ 18 (2,264) 17,384 1,055 (3,117) 21
Ending balance (in shares) at Dec. 31, 2020   1,765          
Increase (Decrease) in Stockholders' Equity              
Net earnings attributable to AbbVie Inc. 11,542 $ 0 0 0 11,542 0 0
Other comprehensive income, net of tax 218 0 0 0 0 218 0
Dividends declared (9,470) 0 0 0 (9,470) 0 0
Purchases of treasury stock (934) $ 0 (934) 0 0 0 0
Purchases of treasury stock (in shares)   (8)          
Stock-based compensation plans and other 976 $ 0 55 921 0 0 0
Stock-based compensation plans and other (in shares)   11          
Change in noncontrolling interest 7 $ 0 0 0 0 0 7
Ending balance at Dec. 31, 2021 15,436 $ 18 (3,143) 18,305 3,127 (2,899) 28
Ending balance (in shares) at Dec. 31, 2021   1,768          
Increase (Decrease) in Stockholders' Equity              
Net earnings attributable to AbbVie Inc. 11,836 $ 0 0 0 11,836 0 0
Other comprehensive income, net of tax 700 0 0 0 0 700 0
Dividends declared (10,179) 0 0 0 (10,179) 0 0
Purchases of treasury stock (1,487) $ 0 (1,487) 0 0 0 0
Purchases of treasury stock (in shares)   (10)          
Stock-based compensation plans and other 976 $ 0 36 940 0 0 0
Stock-based compensation plans and other (in shares)   11          
Change in noncontrolling interest 5 $ 0 0 0 0 0 5
Ending balance at Dec. 31, 2022 $ 17,287 $ 18 $ (4,594) $ 19,245 $ 4,784 $ (2,199) $ 33
Ending balance (in shares) at Dec. 31, 2022   1,769